NCT01427387

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

Phase I Study of ASP0456 - A Double-blind, Placebo-controlled, Multiple Ascending Dose Study / Investigational Study for Dose Timing Selection in Non Elderly Healthy Subjects-

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 20 Years – 44 Years
• Healthy volunteers: Accepted

Summary

A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending dose of ASP0456 in non-elderly healthy subjects. Two dosing condition, pre-prandial and postprandial administrations, is compared.

Conditions

• Healthy
• Pharmacokinetics of ASP0456

Interventions

Type	Name	Description
DRUG	ASP0456	oral
DRUG	Placebo	oral

Timeline

• Start date: 2011-06-01
• Primary completion: 2011-09-01
• Completion: 2011-09-01
• First posted: 2011-09-01
• Last updated: 2011-09-23

Locations

1 site across 1 country: Japan